ADRENAL CORTICAL CARCINOMA
Clinical trials for ADRENAL CORTICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADRENAL CORTICAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADRENAL CORTICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for liver cancers: targeted chemo plus immune booster
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard liver-directed chemotherapy can help people with certain cancers that have spread to the liver. About 70 adults with colorectal, bile duct, or adrenal cancer will receive treatment through a pump place…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:50 UTC
-
Immunotherapy may stall rare adrenal cancer progression
Disease control Recruiting nowThis study tests whether the immunotherapy drug cemiplimab can delay or prevent cancer growth in people with advanced adrenocortical cancer whose disease was controlled by initial chemotherapy. About 31 adults whose cancer did not worsen after 4-6 cycles of first-line treatment w…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New combo therapy holds promise for rare adrenal cancer
Disease control Recruiting nowThis study tests whether combining two drugs, cabozantinib and pembrolizumab, can shrink or slow the growth of advanced adrenal cancer that has spread or cannot be removed by surgery. The trial enrolls 21 adults with this rare cancer, regardless of prior treatments. The goal is t…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Custom mRNA vaccine takes on rare endocrine cancers
Disease control Recruiting nowThis early study tests a personalized mRNA vaccine (mRNA-0523-L001) in 21 adults with advanced endocrine tumors, such as adrenal, thyroid, or pancreatic cancers, that have not responded to standard treatments. The vaccine is designed to train the immune system to attack each pati…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Rare cancer under the microscope: new study aims to unlock secrets of adrenal tumors
Knowledge-focused Recruiting nowThis study looks back at medical records of 60 adults with adrenal cortex carcinoma, a rare cancer. Researchers want to learn how the disease progresses and what affects survival. No new treatments are given; the goal is to gather information to improve future care.
Matched conditions: ADRENAL CORTICAL CARCINOMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC